Jay T. Flatley
Jay T. Flatley's purchase track record
How the stock did after each of Jay T. Flatley's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/17/2024 | RIVN | $11K | +96.7% | +17.2% | +16.3% |
| 7/6/2023 | RIVN | $10K | -15.5% | -9.8% | +6.3% |
| 5/26/2022 | RIVN | $1.17M | +12.6% | +1.0% | -0.8% |
| 5/13/2022 | RIVN | $2K | +45.7% | +30.7% | -0.8% |
| 1/11/2022 | RIVN | $2K | -54.3% | -63.9% | -19.0% |
| 11/15/2021 | RIVN | $1.56M | -58.1% | -83.4% | -14.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Denali Therapeutics Shares Test Fair Value Amid Pullback. Denali Therapeutics shares have pulled back, testing the $19.37 support level. The 14‑day RSI sits at 30, indicating a possible oversold condition, while the support_reject signal suggests the level may hold. Analysts average a target of $36.06, with a range of $27 to $42, well above the current price and the 52‑week low of $13.75. The pullback could be seen as a chance to assess fair value.
Transaction History
| RIVN | ▲ Buy | Grant | 17,445 | $0 | 6/22/2026 | View on chart |
| DNLI | ▲ Buy | Grant | 6,408 | $0 | 6/3/2026 | View on chart |
| RIVN | ▲ Buy | Grant | 16,812 | $0 | 6/18/2025 | View on chart |
| DNLI | ▲ Buy | Grant | 6,037 | $0 | 6/3/2025 | View on chart |
| RIVN | ▲ Buy | Grant | 24,224 | $0 | 6/18/2024 | View on chart |
| DNLI | ▲ Buy | Grant | 5,967 | $0 | 5/31/2024 | View on chart |
| RIVN | ▲ Buy | Open Market | 1,250 | $11K | 4/17/2024 | View on chart |
| RIVN | ▼ Sell | Open Market | 490 | $8K | 10/23/2023 | View on chart |
| RIVN | ▲ Buy | Open Market | 490 | $10K | 7/6/2023 | View on chart |
| RIVN | ▲ Buy | Grant | 18,208 | $0 | 6/21/2023 | View on chart |
| DNLI | ▲ Buy | Grant | 4,216 | $0 | 6/1/2023 | View on chart |
| RIVN | ▼ Sell | Open Market | 3 | $75 | 12/13/2022 | View on chart |
| RIVN | ▼ Sell | Open Market | 57 | $1K | 12/13/2022 | View on chart |
| RIVN | ▲ Buy | Grant | 8,960 | $0 | 6/6/2022 | View on chart |
| DNLI | ▲ Buy | Grant | 5,986 | $0 | 6/2/2022 | View on chart |
| RIVN | ▲ Buy | Open Market | 40,000 | $1.2M | 5/26/2022 | View on chart |
| RIVN | ▲ Buy | Open Market | 60 | $2K | 5/13/2022 | View on chart |
| RIVN | ▼ Sell | Open Market | 30 | $2K | 1/26/2022 | View on chart |
| RIVN | ▲ Buy | Open Market | 30 | $2K | 1/11/2022 | View on chart |
| RIVN | ▲ Buy | Open Market | 20,000 | $1.6M | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Rivian Shares Edge Higher Amid Tesla Roadster News
Rivian stock moved slightly higher after Tesla’s Roadster reveal lifted several EV makers. The modest gain came as the market reacted to Tesla’s announcement, while Rivian’s own fundamentals remain unchanged. The stock is trading near its recent support level and shows a low RSI, indicating limited momentum.
Rivian Shares Edge Higher Amid Tesla Roadster News. Rivian stock moved slightly higher after Tesla’s Roadster reveal lifted several EV makers. The modest gain came as the market reacted to Tesla’s announcement, while Rivian’s own fundamentals remain unchanged. The stock is trading near its recent support level and shows a low RSI, indicating limited momentum.